<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EN" hierarchy="1" humanitarian="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>GB-GOV-13-FUND--Newton-MR_M026205_1</iati-identifier>
  <reporting-org ref="10" type="DEPARTMENT OF BUSINESS, ENERGY AND INDUSTRIAL STRATEGY">
   <narrative xml:lang="EN">1</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Newton 001 Development of new GPCRs interacting drugs to treat inflammatory diseases</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">4</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">The overwhelming systemic inflammatory response triggered by acute infection (sepsis) and its progression into septic shock can lead to progressive organ dysfunction. This condition has a 70-90% mortality rate and is a major public health problem both the UK and Brazil. In Brazil there has been a dramatic increase in the number of sepsis-associated deaths (9.8% in 2002 to 16.5% in 2010). A major challenge in the treatment of sepsis-induced cardiovascular collapse is the fact that it is not responsive to standard vasopressor and inotropic treatments. This situation is aggravated in populations where healthcare provision is not readily accessible, either for socio-economical or geographical reasons, leading to exacerbation of the underlying infection. The proposed work intends to exploit recent knowledge of the ability of drugs to bias responses from cell surface receptors to particular intracellular signalling pathways in order to develop inotropic and vasopressor treatments that are effective in sepsis.</narrative>
  </description>
  <other-identifier type="GB-GOV-13"></other-identifier>
  <activity-status code="2015-01-01"></activity-status>
  <activity-date iso-date="2015-01-14" type="2"></activity-date>
  <activity-date iso-date="2015-12-31" type="3"></activity-date>
  <activity-date iso-date="2016-01-13" type="4"></activity-date>
  <activity-date iso-date="BR" type="BRAZIL"></activity-date>
  <contact-info type="UK RESEARCH &amp; INNOVATION">
   <organisation>
    <narrative xml:lang="EN">International Development</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Newton</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">gcrf@ukri.org</narrative>
   </person-name>
   <email>https://www.ukri.org/</email>
   <website>Polaris House, Swindon, SN2 1LF</website>
   <mailing-address>
    <narrative xml:lang="EN">GBP</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="SOUTH AMERICA, REGIONAL" percentage="100">
   <narrative xml:lang="EN">489</narrative>
  </recipient-country>
  <recipient-region code="1" percentage="100" vocabulary="RESEARCH/SCIENTIFIC INSTITUTIONS"></recipient-region>
  <sector percentage="100" vocabulary="1">
   <narrative xml:lang="EN">43082</narrative>
  </sector>
  <collaboration-type code="10"></collaboration-type>
  <default-flow-type code="110"></default-flow-type>
  <default-finance-type code="D02"></default-finance-type>
  <default-aid-type code="5" vocabulary="1"></default-aid-type>
  <budget status="2" type="1">
   <period-start iso-date="2014-04-01"></period-start>
   <period-end iso-date="2014-03-31"></period-end>
   <value currency="GBP" value-date="2015-01-05">12172.81</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2015-04-01"></period-start>
   <period-end iso-date="2015-03-31"></period-end>
   <value currency="GBP" value-date="2015-01-05">24345.62</value>
  </budget>
  <capital-spend percentage="To establish an intercontinental collaborative consortium between the University of Nottingham and the University of Sao Paulo (Center for Research in Inflammatory Diseases, CRID) for the study of G protein-coupled receptors relevant to inflammatory disease.  To conduct an initial pilot study to develop biased agonists for the beta1-adrenoceptor and evaluate their potential as inotropic agents for the treatment of septic shock following acute infection.  To establish a knowledge transfer partnership to enhance bidirectional transfer of knowledge and training among scientists, postdoctoral fellows and graduate students from the Universities of Nottingham and University of Sao Paulo."></capital-spend>
  <document-link format="HTTPS://WWW.UKRI.ORG/FUNDING/INFORMATION-FOR-AWARD-HOLDERS/GRANT-TERMS-AND-CONDITIONS/" url="A04">
   <title>
    <narrative xml:lang="EN">application/pdf</narrative>
   </title>
   <category code="0"></category>
  </document-link>
  <conditions attached="UK Research &amp; Innovation Grant Terms and Conditions"></conditions>
  <iati-activities>
   <iati-activity>
    <title>
     <narrative xml:lang="2021-09-24"></narrative>
    </title>
   </iati-activity>
  </iati-activities>
 </iati-activity>
</iati-activities>
